Adaptyx Biosciences
Adaptyx Biosciences develops a wearable platform that turns laboratory-grade biochemical assays into continuous molecular data streams. The company enables minimally invasive, real-time monitoring of diverse biomarkers through programmable molecular sensors combined with advanced electronics and AI-driven analytics. The goal is to provide actionable, continuous health insights for clinicians, facilitating proactive, personalized, and always-on healthcare. The technology is designed for versatility across high-impact use cases such as heart failure management, chronic kidney disease, hormone dysregulation, hospital care and precision drug monitoring. The platform is based on a decade of academic innovation, integrating high-throughput molecular engineering, data-driven design, and robust clinical-grade performance.
Industries
N/A
Patents
Products
A minimally-invasive wearable device integrating programmable chemistry, electronics, and AI-driven analytics to continuously collect, analyze, and transmit multi-analyte molecular data from interstitial fluid.
A minimally-invasive wearable device integrating programmable chemistry, electronics, and AI-driven analytics to continuously collect, analyze, and transmit multi-analyte molecular data from interstitial fluid.
Expertise Areas
- Continuous molecular monitoring
- Biosensor engineering
- Digital health data integration
- Clinical biomarker application
Key Technologies
- Programmable molecular switches
- Synthetic DNA-based biosensor architectures
- Minimally-invasive dermal probes
- High-throughput biomolecular screening
Key People
Co-Founder & Scientific Advisor
Co-Founder & Scientific Advisor
Co-Founder & Scientific Advisor
Co-Founder & Scientific Advisor